Literature DB >> 32314315

Valuing the AD-5D Dementia Utility Instrument: An Estimation of a General Population Tariff.

Tracy A Comans1,2, Kim-Huong Nguyen3,4, Julie Ratcliffe5, Donna Rowen6, Brendan Mulhern7.   

Abstract

OBJECTIVE: This paper reports on the valuation of quality-of-life states in the Alzheimer's Disease Five Dimensions (AD-5D) instrument in a representative sample of the general population in Australia using the discrete-choice experiment with duration (DCETTO) elicitation technique.
METHOD: A DCE with 200 choice sets of two quality-of-life (QoL) state-duration combinations blocked into 20 survey versions, with ten choice sets in each version, was designed and administered online to a sample representative of the Australian population. Two additional choice sets comprising internal consistency and dominance checks were included in each survey version. A range of model specifications investigating preferences with respect to duration and interactions between AD-5D dimension levels were estimated. Utility weights were developed, with estimated coefficients transformed to the 0 (being dead) to 1 (full health) scale, suitable for the calculation of quality-adjusted life-year (QALY) weights for use in economic evaluation.
RESULTS: In total, 1999 respondents completed the choice experiment. Overall, respondents were slightly better educated and had higher annual incomes than the Australian general population. The estimation results from different specifications and models were broadly consistent with the monotonic nature of the AD-5D: utility increased with increased life expectancy and decreased as the severity level for each dimension worsened. A utility value set was generated for the calculation of utilities for all QoL states defined by the AD-5D descriptive system.
CONCLUSION: The DCE-based utility value set is now available to use to generate QALYs for the economic evaluation of treatments and interventions targeting people with dementia and/or their family caregivers.

Entities:  

Mesh:

Year:  2020        PMID: 32314315     DOI: 10.1007/s40273-020-00913-7

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  4 in total

1.  Creating 'Partnership in iSupport program' to optimise family carers' impact on dementia care: a randomised controlled trial protocol.

Authors:  Lily Xiao; Ying Yu; Julie Ratcliffe; Rachel Milte; Claudia Meyer; Michael Chapman; Langduo Chen; Shahid Ullah; Alison Kitson; Andre Queiroz De Andrade; Elizabeth Beattie; Henry Brodaty; Sue McKechnie; Lee-Fay Low; Tuan Anh Nguyen; Craig Whitehead; Bianca Brijnath; Ronald Sinclair; Diana Voss
Journal:  BMC Health Serv Res       Date:  2022-06-10       Impact factor: 2.908

2.  Development of a preference-based heart disease-specific health state classification system using MacNew heart disease-related quality of life instrument.

Authors:  Sanjeewa Kularatna; Donna Rowen; Clara Mukuria; Steven McPhail; Gang Chen; Brendan Mulhern; Jennifer A Whitty; Joshua Byrnes; Paul Scuffham; John Atherton; Stefan Höfer; William Parsonage
Journal:  Qual Life Res       Date:  2021-05-26       Impact factor: 4.147

3.  Systematic review of 29 self-report instruments for assessing quality of life in older adults receiving aged care services.

Authors:  Joyce Siette; Gilbert Thomas Knaggs; Yvonne Zurynski; Julie Ratcliffe; Laura Dodds; Johanna Westbrook
Journal:  BMJ Open       Date:  2021-11-18       Impact factor: 2.692

4.  Valuing the Quality-of-Life Aged Care Consumers (QOL-ACC) Instrument for Quality Assessment and Economic Evaluation.

Authors:  Julie Ratcliffe; Siobhan Bourke; Jinhu Li; Brendan Mulhern; Claire Hutchinson; Jyoti Khadka; Rachel Milte; Emily Lancsar
Journal:  Pharmacoeconomics       Date:  2022-08-04       Impact factor: 4.558

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.